Abiomed reports preliminary q3 revenue of $222 mln

Abiomed announces preliminary q3 fy 2020 revenue of $222 million, up 10% over prior year.q3 revenue $222 million versus refinitiv ibes estimate of $226.7 million.updating its fiscal year 2020 revenue guidance to be in range of $846 million to $877 million.fy2020 revenue view $885.8 million -- refinitiv ibes data.
ABMD Ratings Summary
ABMD Quant Ranking